Quantification of Bone Involvement in Gaucher Disease: MR Imaging Bone Marrow Burden Score as an Alternative to Dixon Quantitative Chemical Shift MR Imaging - Initial Experience

Radiology

Volumn 229, Issue 2, 2003, Pages 554-561

  Maas, Mario ^a   Van Kuijk, Cornelis ^a   Stoker, Jaap ^a   Hollak, Carla E M ^a   Akkerman, Erik M ^a   Aerts, Johannes F M G ^a   Den Heeten, Gerard J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Bone marrow, diseases; Bone marrow, MR; Gaucher disease; Magnetic resonance (MR), chemical shift

Indexed keywords

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW; BONE MARROW BURDEN SCORE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIXON QUANTITATIVE CHEMICAL SHIFT IMAGING; ENZYME THERAPY; FAT FRACTION MEASUREMENT; FEMALE; FEMUR; GAUCHER DISEASE; HUMAN; INTERMETHOD COMPARISON; LUMBAR SPINE; MALE; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANK SUM TEST; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TWO TAILED NONPARAMETRIC RANK CORRELATION;

ADOLESCENT; ADULT; AGED; BONE MARROW; BONE MARROW DISEASES; CHILD; FEMALE; FEMUR; GAUCHER DISEASE; HUMANS; LUMBAR VERTEBRAE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS;

EID: 0142178308     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2292020296     Document Type: Article

References (36)

1. Lee RE. The pathology of Gaucher disease. In: Desnick RJ, Gatt S, Grabowski GA, eds. Gaucher disease: a century of delineation and research. New York, NY: Liss, 1982; 177-217.
2. Beutler E, Grabowski G. Gaucher disease. In: Scriver CR, Sly WS, Valle D, eds. The metabolic basis of inherited disease. New York, NY: McGraw-Hill, 1995; 2641-2670.
3. Charrow J, Esplin JA, Gribble TJ, et al. Gaucher disease: recommendations on diagnosis, evaluation, and monitoring. Arch Intern Med 1998; 158:1754-1760.
4. Stowens DW, Teitelbaum SL, Kahn AJ, Barranger JA. Skeletal complications of Gaucher disease. Medicine 1985; 64:310-322.
5. Barton NW, Brady RO, Dambrosia JM, et al. Dose dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher disease. J Pediatr 1992; 120:277-280.
6. Hollak CE, Aerts JM, Goudsmit R, et al. Individualised low-dose alglucerase therapy for type 1 Gaucher's disease. Lancet 1995; 345:1474-1478.
7. Rosenthal DI, Doppelt SH, Mankin HJ, et al. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics 1995; 96:629-637.
8. Vogler JB III, Murphy WA. Bone marrow imaging. Radiology 1988; 168:679-693.
9. Cremin BJ, Davey H, Goldblatt J. Skeletal complications of type 1 Gaucher disease: the magnetic resonance features. Clin Radiol 1990; 41:244-247.
10. Rosenthal DI, Scott JA, Barranger J, et al. Evaluation of Gaucher disease using magnetic resonance imaging. J Bone Joint Surg Am 1986; 68:802-808.
11. Hermann G, Shapiro RS, Abdelwahab IF, Grabowski G. MR imaging in adults with Gaucher disease type 1: evaluation of marrow involvement and disease activity. Skeletal Radiol 1993; 22:247-251.
12. Lecouvet FE, Vande Berg BC, Michaux L, et al. Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging. Radiology 1998; 209: 653-660.
13. Moulopoulos LA, Dimopoulos MA. Magnetic resonance imaging of the bone marrow in hematologic malignancies. Blood 1997; 90:2127-2147.
14. Steiner RM, Mitchell DG, Rao VM, Schweitzer ME. Magnetic resonance imaging of diffuse bone marrow disease, Radiol Clin N Am 1993; 31:383-409.
15. Rosenthal DI, Barton NW, McKusick KA, et al, Quantitative imaging of Gaucher disease. Radiology 1992; 185:841-845.
16. Johnson LA, Hoppel BE, Gerard EL, et al. Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease. Radiology 1992; 182: 451-455.
17. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984; 153:189-194.
18. Miller SPF, Zirzow GC, Doppelt SH, Brady RO, Barton NW. Analysis of the lipids of normal and Gaucher bone marrow. J Lab Clin Med 1996; 127:353-358.
19. Maas M, Akkerman EM, Hollak CEM, Rademakers RP. Evaluation of skeletal involvement in M. Gaucher: use of quantitative chemical shift imaging (QCSI). Eur Radiol 1997; 7(suppl):206.
20. Rosenthal DI, Doppelt SH, Mankin HJ, et al. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics 1995; 96:629-637.
21. O'Keeffe D, Rosenthal DI. Computed tomography and magnetic resonance imaging in Gaucher's disease. In: Bloem JL, Sartoris DJ, eds. MRI and CT of the musculoskeletal system: a text-atlas. Baltimore, Md: Williams & Wilkins, 1992; 130-138.
22. Maas M, Akkerrnan EM, Venema HW, Stoker J, Den Heeten GJ. Dixon quantitative chemical shift MRI for bone marrow evaluation in the lumbar spine: a reproducibility study in healthy volunteers. J Comput Assist Tomogr 2001; 25:691-697.
23. Rosen BR, Fleming DM, Kushner DC, et al. Hematologic bone marrow disorders: quantitative chemical shift MR imaging. Radiology 1988; 169:799-804.
24. Gerard EL, Ferry JA, Amrein PC, et al. Compositional changes in vertebral bone marrow during treatment for acute leukemia: assessment with quantitative chemical shift imaging. Radiology 1992; 183: 39-46.
25. Gückel F, Brix G, Semmler W, et al. Proton chemical shift imaging of bone marrow for monitoring therapy in leukemia. J Comput Assist Tomogr 1990; 14:945-959.
26. Terk MR, Esplin J, Lee K, Magre G, Colletti PM. MR imaging of patients with type 1 Gaucher's disease: relationship between bone and visceral changes. AJR Am J Roentgenol 1995; 165:599-604.
27. Terk MR, Dardashti S, Liebman HA. Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume. Skeletal Radiol 2000; 29: 563-571.
28. Poll LW, Koch JA, vom Dahl S, et al. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results. Skeletal Radiol 2001; 30:496-503.
29. Sibille A, Eng CM, Kim SJ, Pastores G, Grabowski GA. Phenotype/genotype correlations in Gaucher disease type 1: clinical and therapeutic implications. Am J Hum Genet 1993; 52:1094-1101.
30. Sidransky E, Ginns EI. Phenotypic and genotypic heterogeneity in Gaucher disease: implications for genetic counseling. J Genet Counsel 1994; 3:13-22.
31. Boot RG, Hollak CEM, Verhoek M, et al. Glucocerebrosidase genotype of Gaucher patients in the Netherlands: limitations in prognostic value. Hum Mutat 1997; 10:348-358.
32. Moulopoulos LA, Varma DGK, Dimopoulos MA, et al. Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease. Radiology 1992; 185:833-840.
33. Algra PR, Bloem JL, Valk J. Disappearance of the basivertebral vein: a new MR imaging sign of bone marrow disease. AJR Am J Roentgenol 1991; 157:1129-1130.
34. Cummings SR, Black DB. Should perimenopausal women be screened for osteoporosis? Ann Intern Med 1986; 104: 817-823.
35. Akkerman EM, Maas M. A region-growing algorithm to simultaneously remove dephasing influences and separate fat and water in two-point Dixon imaging (abstr). In: Proceedings of the Society of Magnetic Resonance in Medicine and the European Society of Magnetic Resonance in Medicine and Biology. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1995; 649.
36. Hollak C, Maas M, Akkerman EM, den Heeten A, Aerts H. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disesase. Blood Cells Mol Dis 2001; 27:1005-1012.